Matsuguma C - Search Results

1

Circulating endothelial glycocalyx components as a predictive marker of coronary artery lesions in Kawasaki disease.

Ohnishi Y, Yasudo H, Suzuki Y, Furuta T, Matsuguma C, Azuma Y, Miyake A, Okada S, Ichihara K, Ohga S, Hasegawa S. Ohnishi Y, et al. Among authors: matsuguma c. Int J Cardiol. 2019 Oct 1;292:236-240. doi: 10.1016/j.ijcard.2019.05.045. Epub 2019 May 22. Int J Cardiol. 2019. PMID: 31200965

2

[Refractory primary immune thrombocytopenia in pregnancy requiring splenectomy and repeated intravenous immunoglobulin therapy].

Kajimura Y, Tanaka Y, Nohno S, Tanaka M, Nakamura Y, Yujiri T, Matsukuma S, Nagano H, Matsuguma C, Takahashi K, Hasegawa S, Tanizawa Y. Kajimura Y, et al. Among authors: matsuguma c. Rinsho Ketsueki. 2018;59(12):2574-2577. doi: 10.11406/rinketsu.59.2574. Rinsho Ketsueki. 2018. PMID: 30626791 Japanese.

3

Dynamics of immunocyte activation during intravenous immunoglobulin treatment in Kawasaki disease.

Matsuguma C, Wakiguchi H, Suzuki Y, Okada S, Furuta T, Ohnishi Y, Azuma Y, Ohga S, Hasegawa S. Matsuguma C, et al. Scand J Rheumatol. 2019 Nov;48(6):491-496. doi: 10.1080/03009742.2019.1604992. Epub 2019 Jul 5. Scand J Rheumatol. 2019. PMID: 31272272

4

Utility of Soluble CD163 in the Clinical Management of Patients With Kawasaki Disease.

Azuma Y, Suzuki Y, Okada S, Matsuguma C, Wakiguchi H, Ohnishi Y, Furuta T, Miyake A, Yasudo H, Ichihara K, Ohga S, Hasegawa S. Azuma Y, et al. Among authors: matsuguma c. Front Pediatr. 2020 Apr 7;8:148. doi: 10.3389/fped.2020.00148. eCollection 2020. Front Pediatr. 2020. PMID: 32318530 Free PMC article.

5

Severe persistent pulmonary hypertension in a neonate with Rubinstein-Taybi syndrome accompanied by triple X syndrome.

Matsuguma C, Takahashi K, Okada S, Hasegawa S. Matsuguma C, et al. Pediatr Neonatol. 2022 Mar;63(2):200-201. doi: 10.1016/j.pedneo.2021.08.006. Epub 2021 Sep 2. Pediatr Neonatol. 2022. PMID: 34507883 Free article. No abstract available.

6

Circulating immunocompetent cell profiles during oral cyclosporin therapy for immunoglobulin-resistant Kawasaki disease.

Okada S, Ohnishi Y, Furuta T, Suzuki Y, Kawakami-Miyake A, Matsuguma C, Waniishi T, Yasudo H, Hasegawa S. Okada S, et al. Among authors: matsuguma c. World J Pediatr. 2021 Dec;17(6):671-673. doi: 10.1007/s12519-021-00468-3. Epub 2021 Oct 7. World J Pediatr. 2021. PMID: 34618328 No abstract available.

7

Interleukin-33/ST2 Axis as Potential Biomarker and Therapeutic Target in Kawasaki Disease.

Okada S, Yasudo H, Ohnishi Y, Matsuguma C, Fukano R, Motonaga T, Waniishi T, Hasegawa S. Okada S, et al. Among authors: matsuguma c. Inflammation. 2023 Feb;46(1):480-490. doi: 10.1007/s10753-022-01753-7. Epub 2022 Oct 8. Inflammation. 2023. PMID: 36208354

8

Interleukin-33 and Soluble ST2 Levels in Infants with Hypoxic-Ischemic Encephalopathy.

Hamano H, Takahashi K, Kimura S, Matsuguma C, Kaneyasu H, Fujimoto Y, Ohta N, Okada S, Hasegawa S. Hamano H, et al. Among authors: matsuguma c. Neonatology. 2023;120(3):353-362. doi: 10.1159/000529679. Epub 2023 Mar 30. Neonatology. 2023. PMID: 36996771

9

Clinical utility of gastric fluid cytokine levels in preterm infants for predicting histological chorioamnionitis.

Matsuguma C, Takahashi K, Okada S, Tokitaka R, Hamano H, Kaneyasu H, Fujimoto Y, Hasegawa S. Matsuguma C, et al. Cytokine. 2024 Aug;180:156642. doi: 10.1016/j.cyto.2024.156642. Epub 2024 May 14. Cytokine. 2024. PMID: 38749278

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters